Population analysis of the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812) in treating experimental influenza A and B virus in healthy volunteers
Journal Title: The AAPS Journal - Year 2002, Vol 4, Issue 4
Abstract
Our objective was to assess the pharmacokinetics and pharmacodynamics of RWJ-270201 (BCX-1812), an oral neuraminidase inibitor for the treatment of influenza A and B virus in healthy volunteers.
Authors and Affiliations
Ganesh R. Iyer, Sam Liao, Joseph Massarella
Keywords
Related Articles
- EP ID EP682014
- DOI 10.1208/ps040422
- Views 110
- Downloads 0
Monoamine oxidase inhibitory properties of some benzazoles: Structure-; Activity relationships
Benzazoles containing two or three nitrogen atoms were screened for their inhibitory activity toward monoamine oxidases MAO-A and MAO-B. In order to clarify the mechanism of interaction of these compounds with the enzyme...
Prediction of Exposure–Response Relationships to Support First-in-Human Study Design
In drug development, phase 1 first-in-human studies represent a major milestone as the drug moves from preclinical discovery to clinical development activities. The safety of human subjects is paramount to the conduct of...
Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective
The online version of this article (doi:10.1208/s12248-013-9470-x) contains supplementary material, which is available to authorized users.
Fish pharmacokinetics database updated
Characterization of Supersaturatable Formulations for Improved Absorption of Poorly Soluble Drugs
With the increasing number of poorly water-soluble compounds in contemporary drug discovery pipelines, the concept of supersaturation as an effective formulation approach for enhancing bioavailability is gaining momentum...